Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Life sciences company Revive Therapeutics Ltd. (OTCQB:RVVTF) is advancing its first Phase I/II clinical trial of oral psilocybin for methamphetamine use disorder treatment while also developing an oral psilocybin thin film strip product.
Revive is currently studying psilocybin’s potential as treatment for the addiction of this particular stimulant drug together with the University of Wisconsin-Madison. The Phase I/II clinical trial holds both FDA and the Institutional Review Board approval, and is being led by Dr. Christopher Nicholas and Dr. Paul Hutson.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
The clinical data is expected to give further insight on the safety, efficacy and dosing of oral psilocybin and, if applied, to support future clinical studies for Revive’s novel oral psilocybin thin film strip product to be conducted in 2023.
The company’s proprietary psilocybin product is being developed jointly with pharma oral thin films leader LTS Lohmann Therapie-Systeme AG. Prototypes of the new creation have been developed and are currently being optimized for its use in upcoming IND-enabling studies.
Revive is using its recently acquired Psilocin Pharma Corp. to advance the development of a psilocybin-based therapeutics pipeline for various health indications including mental illness, substance abuse and neurological disorders.
Meanwhile, the company also holds a cannabinoid pharma portfolio, which is focused on rare inflammatory diseases. The FDA granted Revive an orphan drug status designation for the use of cannabidiol (CBD) to treat autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation.
Photo Courtesy of Susie Hedberg and only_kim on Shutterstock.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.